Michael Soliman

MD | Neurology


  1542 Tulane Ave Fl 7, New Orleans
     Louisiana, 70112-2865
  504-568-4081    504-568-7130 Maps & Directions
Michael Soliman is a New Orleans, Louisiana based neurologist who is specialized in Neurology. His current practice location is 1542 Tulane Ave Fl 7, New Orleans. Patients can reach him at 504-568-4081 or can fax him at 504-568-7130. Michael Soliman is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1720518475.
Michael Soliman specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Michael Soliman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Michael Soliman
Specialization: Neurology
Gender:Male
Credentials: MD
Practice Address:1542 Tulane Ave Fl 7, New Orleans,
Louisiana, 70112-2865
Phone:504-568-4081
Fax:504-568-7130
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1720518475
NPI Enumeration Date: 15 Jun, 2017
NPI Last Update On: 06 Sep, 2023

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Michael Soliman
1542 Tulane Ave, 7th Floor, Department Of Neurology - Residency Program
New Orleans, Louisiana
Zip: 70112-2865
Phone Number: 504-568-4081
Fax Number: 504-568-7130
Patients can reach Michael Soliman at 1542 Tulane Ave Fl 7, New Orleans, Louisiana or can call to book an appointment on 504-568-4081.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.